Resources|Articles|November 8, 2024
mAbs Scale-up video
Author(s)Avantor
Scaling up monoclonal antibody (mAb) production can be challenging, but it doesn't have to slow you down. Explore how our large-volume handling solutions, GMP-grade chemicals and customized solutions for process development, optimization, and validation help you scale up quickly and meet regulatory standards with confidence.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
2
ACG Introduces SuperPod for Drug Protection and Sustainability
3
PharmTech Weekly News Roundup – Week of January 19, 2026
4
Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production
5